[go: up one dir, main page]

HRP20110200T1 - Uporaba tiotropijevih soli u liječenju umjereno postojane astme - Google Patents

Uporaba tiotropijevih soli u liječenju umjereno postojane astme Download PDF

Info

Publication number
HRP20110200T1
HRP20110200T1 HR20110200T HRP20110200T HRP20110200T1 HR P20110200 T1 HRP20110200 T1 HR P20110200T1 HR 20110200 T HR20110200 T HR 20110200T HR P20110200 T HRP20110200 T HR P20110200T HR P20110200 T1 HRP20110200 T1 HR P20110200T1
Authority
HR
Croatia
Prior art keywords
treatment
use according
asthma
patients
preparation
Prior art date
Application number
HR20110200T
Other languages
English (en)
Croatian (hr)
Inventor
Engel Michael
Heinrichs Stefan
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35695896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110200(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of HRP20110200T1 publication Critical patent/HRP20110200T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20110200T 2006-01-04 2006-12-22 Uporaba tiotropijevih soli u liječenju umjereno postojane astme HRP20110200T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100055 2006-01-04
PCT/EP2006/070135 WO2007077162A1 (en) 2006-01-04 2006-12-22 Use of tiotropium salts in the treatment of moderate persistent asthma

Publications (1)

Publication Number Publication Date
HRP20110200T1 true HRP20110200T1 (hr) 2011-04-30

Family

ID=35695896

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110200T HRP20110200T1 (hr) 2006-01-04 2006-12-22 Uporaba tiotropijevih soli u liječenju umjereno postojane astme

Country Status (30)

Country Link
US (2) US20070155773A1 (uk)
EP (1) EP1971332B1 (uk)
JP (1) JP2009525950A (uk)
KR (1) KR20080083060A (uk)
CN (1) CN101355937A (uk)
AR (1) AR059126A1 (uk)
AT (1) ATE500825T1 (uk)
AU (1) AU2006334367B2 (uk)
BR (1) BRPI0620886A2 (uk)
CA (1) CA2634984C (uk)
CY (1) CY1111534T1 (uk)
DE (1) DE602006020620D1 (uk)
DK (1) DK1971332T3 (uk)
EA (1) EA015353B1 (uk)
EC (1) ECSP088588A (uk)
ES (1) ES2362306T3 (uk)
HR (1) HRP20110200T1 (uk)
IL (1) IL192602A (uk)
ME (1) ME01205B (uk)
MY (1) MY146362A (uk)
NO (1) NO20082439L (uk)
NZ (1) NZ570162A (uk)
PL (1) PL1971332T3 (uk)
PT (1) PT1971332E (uk)
RS (1) RS51703B (uk)
SI (1) SI1971332T1 (uk)
TW (1) TW200731976A (uk)
UA (1) UA95271C2 (uk)
WO (1) WO2007077162A1 (uk)
ZA (1) ZA200804436B (uk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2617717C (en) 2005-08-06 2014-02-11 Boehringer Ingelheim International Gmbh Use of tiotropium salts in the treatment of severe persistant asthma
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
CN110876720A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 依地酸盐恰当改变噻托溴铵喷雾剂表面张力的应用
CN110876721A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 一种含有表面活性剂的噻托溴铵喷雾剂

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2425539A (en) * 1942-10-31 1947-08-12 Aro Equipment Corp Coupling
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
EP1326862B1 (de) * 2000-10-12 2004-09-15 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Kristallines monohydrat von tiotropiumbromid, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
US8686148B2 (en) * 2003-11-03 2014-04-01 Boehringer Ingelheim International Gmbh Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
JP4553902B2 (ja) * 2003-11-03 2010-09-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用を有する新規結晶性無水物
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
US20060269946A1 (en) * 2005-05-10 2006-11-30 Young Robert P Methods and compositions for assessment of pulmonary function and disorders
US7933722B2 (en) * 2005-05-20 2011-04-26 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
CA2617717C (en) * 2005-08-06 2014-02-11 Boehringer Ingelheim International Gmbh Use of tiotropium salts in the treatment of severe persistant asthma
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide

Also Published As

Publication number Publication date
MY146362A (en) 2012-08-15
ATE500825T1 (de) 2011-03-15
SI1971332T1 (sl) 2011-05-31
AU2006334367A1 (en) 2007-07-12
DE602006020620D1 (de) 2011-04-21
KR20080083060A (ko) 2008-09-12
US20070155773A1 (en) 2007-07-05
ECSP088588A (es) 2008-07-30
US20150224090A1 (en) 2015-08-13
EA015353B1 (ru) 2011-06-30
AR059126A1 (es) 2008-03-12
ZA200804436B (en) 2008-12-31
NO20082439L (no) 2008-08-04
DK1971332T3 (da) 2011-04-18
EP1971332A1 (en) 2008-09-24
PL1971332T3 (pl) 2011-08-31
ES2362306T3 (es) 2011-07-01
AU2006334367B2 (en) 2012-11-08
EP1971332B1 (en) 2011-03-09
NZ570162A (en) 2011-09-30
ME01205B (me) 2013-03-20
CA2634984A1 (en) 2007-07-12
EA200801629A1 (ru) 2008-12-30
IL192602A0 (en) 2009-09-22
TW200731976A (en) 2007-09-01
UA95271C2 (uk) 2011-07-25
PT1971332E (pt) 2011-03-18
IL192602A (en) 2013-06-27
CN101355937A (zh) 2009-01-28
RS51703B (sr) 2011-10-31
CA2634984C (en) 2014-05-06
WO2007077162A1 (en) 2007-07-12
CY1111534T1 (el) 2015-08-05
BRPI0620886A2 (pt) 2011-11-29
JP2009525950A (ja) 2009-07-16

Similar Documents

Publication Publication Date Title
ES2395159T3 (es) Terapia con pirfenidona e inductores del citocromo P450
HRP20192114T1 (hr) Deuterirani derivati ivakaftora
JP2011162556A5 (uk)
HRP20110232T1 (hr) Antagonisti muskarinskog acetilkolinskog receptora
RU2013148732A (ru) Комбинации соединений, ингибирующих акт, и химиотерапевтических агентов и способы их применения
JP2013209384A5 (uk)
HRP20180312T1 (hr) Kombinacije antagonista muskarinskog receptora i agonista adrenoreceptora beta-2
TW200524639A (en) Memantine oral dosage forms
EP2197444A1 (en) Novel combination of therapeutic agents
PH12014502662A1 (en) Novel dosage form and formulation of abediterol
CN102470099A (zh) 儿童用奥洛他定鼻腔喷雾方案
CN107233311A (zh) 一种以阿福特罗和格隆溴铵为活性成分的雾化剂及其制备方法
US20210401851A1 (en) Par-4 agonists for the treatment of cancer
JP2012502103A5 (uk)
HRP20110200T1 (hr) Uporaba tiotropijevih soli u liječenju umjereno postojane astme
CN103263416A (zh) 一种吡啶胺化合物在制备适于口服给药的治疗肺癌的药物中的应用
CN101062041B (zh) 葫芦素新的医药用途
JP2017508004A5 (uk)
CN114053216A (zh) 一种吸入用芜地溴铵溶液制剂及其制备方法
CN109260180A (zh) 一种盐酸莫西沙星雾化吸入用溶液制剂及其制备方法
CN102319208A (zh) 一种治疗化放疗所致口腔黏膜炎的悬浮液组合物
TW200936166A (en) Pharmaceutical composition and combined agent
CN102319260A (zh) 顺铂联合伊曲康唑异构体在制备治疗肺癌药物中的应用
JP6549107B2 (ja) がんの処置のための、ｒｏ５５０３７８１、カペシタビン及びオキサリプラチンの組み合わせ
JP2009504604A5 (uk)